Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy.
about
Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophyInduction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status.Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencingClinical and genetic characterization of manifesting carriers of DMD mutationsCarrier detection in Duchenne muscular dystrophy using molecular methods.Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin.Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online databaseTargeted exon skipping to correct exon duplications in the dystrophin gene.Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants.Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.
P2860
Q33526335-B2CF387C-08D6-4053-BF09-4D8077C9F5A4Q33604775-C1E74DF5-2024-4E44-88DC-3DD913B07F0FQ33843901-53EE8A7E-E673-434D-9FF0-98A111BF19D6Q34151973-9663C10D-A6FC-4B87-8C5C-E9D7B5AEB858Q37073219-C382A4D9-DDD6-4BB1-84E9-55B6C438E368Q37102146-AD2FC2C9-921C-4A13-9AA3-E4BF522D5AB7Q37109015-E36C504C-A308-4A4B-B7B1-64E540B953C1Q37695543-13F7F252-A284-4387-A785-76D7DF57D808Q41845181-829DD880-7D26-490D-97AB-252F2A7E1772Q42094546-6DD8D0CB-88C6-4056-81A4-114A153ACAB0Q51677375-9011154F-D223-49DE-B204-65DF0FBC4975Q51770570-CE2B4910-4272-4DCA-AABD-34FEE1819996
P2860
Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@en
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@nl
type
label
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@en
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@nl
prefLabel
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@en
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@nl
P2093
P2860
P356
P1476
Measurement of the clinical ut ...... and Becker muscular dystrophy.
@en
P2093
Aurora Baumli
Benito Prósper-Gutiérrez
Christopher G Bell
Corrina Walsh
David R Mowat
Fernando De La Puente-Alonso
George Elakis
Glenda L Mullan
Heather M Johnston
Michael F Buckley
P2860
P304
P356
10.1136/JMG.2006.047464
P407
P577
2007-01-26T00:00:00Z